Hangzhou Jiuyuan Genetic Biopharmaceutical (02566) published its monthly return for the period ended 31 October 2025. The registered share capital remained at RMB 245,398,800, comprising 109,096,785 H shares, 105,302,015 domestic shares, and 31,000,000 unlisted foreign shares. No variations in the number of issued shares or treasury shares were reported, and there were no outstanding share options, warrants, or other convertible securities during the period.